Market open
Daxor/$DXR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Daxor
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.
Ticker
$DXR
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
45
Website
Daxor Metrics
BasicAdvanced
$37M
68.54
$0.11
-0.53
-
Price and volume
Market cap
$37M
Beta
-0.53
52-week high
$8.83
52-week low
$7.15
Financial strength
Current ratio
0.168
Quick ratio
0.088
Long term debt to equity
2.039
Total debt to equity
2.039
Interest coverage (TTM)
-16.89%
Management effectiveness
Return on assets (TTM)
-2.51%
Return on equity (TTM)
1.54%
Valuation
Price to earnings (TTM)
68.538
Price to revenue (TTM)
307.06
Price to book
1.03
Price to tangible book (TTM)
1.03
Price to free cash flow (TTM)
1,431.022
Growth
Revenue change (TTM)
-26.75%
Earnings per share change (TTM)
86.16%
3-year revenue growth (CAGR)
-24.49%
3-year earnings per share growth (CAGR)
-54.78%
Daxor News
AllArticlesVideos
Daxor Corporation Announces New Data from Duke University and Highlights Key BVA Insights at American College of Cardiology's 74th Annual Scientific Session and Expo
GlobeNewsWire·6 days ago
Daxor Expands Blood Volume Analysis Technology Across Midwest, Wisconsin, and New Jersey Healthcare Networks
GlobeNewsWire·2 weeks ago
Daxor Corporation (DXR) Q4 2024 Earnings Call Transcript
Seeking Alpha·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Daxor stock?
Daxor (DXR) has a market cap of $37M as of April 08, 2025.
What is the P/E ratio for Daxor stock?
The price to earnings (P/E) ratio for Daxor (DXR) stock is 68.54 as of April 08, 2025.
Does Daxor stock pay dividends?
No, Daxor (DXR) stock does not pay dividends to its shareholders as of April 08, 2025.
When is the next Daxor dividend payment date?
Daxor (DXR) stock does not pay dividends to its shareholders.
What is the beta indicator for Daxor?
Daxor (DXR) has a beta rating of -0.53. This means that it has an inverse relation to market volatility.